NDAQ:BPAX - Post Discussion
Post by
investology on Jun 22, 2008 1:03am
Bold endeavour
(Source: Red Orbit, Marcial: BioSante May Be Buyout Bait)
Biosante, by involving in the development of a drug that restores a woman's sexual desire, has decided to take a step that both Procter & Gamble and Pfizer feared to take.
Analysts have shown extreme optimism by stating that a company looking to acquire Biosante may even have to hit the $11 a share mark. This has obviously steered investor attention after Biosante appointed Deutsche Bank to pan out a strategy.
An eye must be kept on this stock close to late 2009, which is when the phase III results are expected to be revealed.
Be the first to comment on this post